{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibznn6xhdrubp5y6x2cz6b4x3ewmue6hnyi7vhs3r2ial7zfz7eme",
    "uri": "at://did:plc:svcthvzunxmjidtlw23zva6n/app.bsky.feed.post/3mh6jqjty4z32"
  },
  "path": "/2026/03/16/alar-announced-buprenorphine-injectable-ala-1000-demonstrated-long-term-efficacy-and-favorable-safety-profile-in-canine-osteoarthritis-pain-management/",
  "publishedAt": "2026-03-16T12:00:00.000Z",
  "site": "https://laotiantimes.com",
  "tags": [
    "Cision PR Newswire"
  ],
  "textContent": "A study in client-owned dogs with osteoarthritis demonstrated that a single injection of ALA-1000 effectively mitigates pain and improves functional mobility, with a sustained drug release profile for at least 1 month. The study also confirmed a favorable safety profile with repeated use, particularly within the geriatric population. TAICHUNG, March 16, 2026 /PRNewswire/ — Alar […]",
  "title": "Alar Announced Buprenorphine Injectable, ALA-1000, Demonstrated Long-Term Efficacy and Favorable Safety Profile in Canine Osteoarthritis Pain Management"
}